KLRC1 and COVID-19: Interestingly, all 3 subjects experiencing COVID-19 in the Mw group beyond 150 days, had low baseline ANK cells and 2 of the 3 subjects did not show any increment in NKG2C+ANK levels or NKG2C/NKG2A ratios at any of the time-points.